Results

Total Results: 423 records

Showing results for "aspirin".

241. Final Research Plan: Enhanced Risk Assessment for Cardiovascular Disease: Coronary Artery Calcium Scoring | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/cardiovascular-disease-enhanced-risk-assessment-non-traditional-risk-factors
     September 26, 2024 - other risk factors (KQs 1 and 3 only) KQs 4, 5: Interventions aimed at preventing CVD events: Aspirin

242. High-Priority Evidence Gaps For Clinical Preventive Services: 7th Annual Report to Congress (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annual-report-to-congress-2017%20(2).pdf
     January 01, 2017 - B Aspirin to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication in Adults Ages … 50 to 59 Years The USPSTF recommends initiating low-dose aspirin use for the primary prevention of … B Aspirin to Prevent Morbidity and Mortality From Preeclampsia: Preventive Medication in Pregnant Women … The USPSTF recommends the use of low-dose aspirin (81 mg/day) as preventive medication after 12 weeks … I Aspirin to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication in Adults Age

243. Eighth Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/usptf-annual-report-congress-2018%20(1).pdf
     January 01, 2018 - B Aspirin to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication in Adults … Ages 50 to 59 Years The USPSTF recommends initiating low-dose aspirin use for the primary prevention … C Aspirin to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication in Adults … I Aspirin to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication in Adults … I Aspirin to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication in Adults

244. Ykjvkfmv5Jf8Bl3Rbx8Bp7 (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/ykjVKfmV5Jf8bL3rBx8BP7
     December 01, 2015 - The evidence review assessed the benefits and harms of aspirin use and intensive versus standard control … Benefits of Aspirin Use The USPSTF identified 2 systematic reviews (34, 35) that found no significant … differences in RR reduction be- tween aspirin use and nonuse in persons with diabetes. … Effects of intensive blood-pressure lowering and low- dose aspirin in patients with hypertension: principal … Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised

245. Archived: Final Evidence Summary: Vitamin Supplementation to Prevent Cancer and CVD: Counseling and Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary53/vitamin-supplementation-to-prevent-cancer-and-cvd-counseling-and-preventive-medication-2003
     July 01, 2003 - Health Study, focusing on health professionals, is a factorial study of beta-carotene, vitamin E, and aspirin … ; the beta-carotene arm has been closed, but the vitamin E and aspirin arms continue. … Noncompliance in run-in phase. 50 mg beta-carotene on alternate days; cointervention with 325 mg aspirin … Adjustment was made for alcohol use, smoking history, aspirin use, and medical conditions. 9. … Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice

246. Routine Vitamin Supplementation to Prevent Cancer: A Summary of the Evidence From Randomized Controlled Trials (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/WQn9bgKKtztGXQN9dwUSby
     July 01, 2003 - • noncompliance in run-in phase 50 mg beta-carotene on alternate days; cointervention with 325 mg aspirin … professionals > 45 years 50 mg beta-carotene on alternate days vs placebo; cointervention with 100 mg aspirin … ; the beta-carotene arm has been closed, but the vitamin E and aspirin arms continue. … Adjustment was made for alcohol use, smoking history, aspirin use, and medical conditions. 9. … Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice

247. Archived: Carotid Artery Stenosis: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/carotid-artery-stenosis-screening-july-2014
     July 08, 2014 - In addition, the USPSTF recommends the use of aspirin for persons at increased risk for cardiovascular … In addition, the USPSTF recommends the use of aspirin for persons at increased risk for cardiovascular … therapy varied across trials and was not clearly defined or standardized, although all patients received aspirin … trials include the CASANOVA (Carotid Artery Stenosis with Asymptomatic Narrowing: Operation Versus Aspirin

248. Draft Recommendation: Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/menopausal-hormone-therapy-postmenopausal-persons-primary-prevention-chronic-conditions
     April 19, 2022 - related to the prevention of cardiovascular disease and other chronic conditions in adults, including aspirin … Aspirin Use to Prevent Cardiovascular Disease: U.S. … https://www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/aspirin-use-to-prevent-cardiovascular-disease-preventive-medication

249. 12th Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/2022-annual-report-to-congress.pdf
     January 01, 2022 - Draft Recommendation Aspirin Use to Prevent Cardiovascular Disease Counseling to Promote a Healthy … Use to Prevent Cardiovascular Disease (CVD) The decision to initiate low-dose aspirin use for the … Evidence indicates that the net benefit of aspirin use in this group is small. … Persons who are not at increased risk for bleeding and are willing to take low-dose aspirin daily are … (Grade C) The USPSTF recommends against initiating low-dose aspirin use for the primary prevention

250. Current Processes: Refining Evidence-based Recommendation Development | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/current-processes-refining-evidence-based-recommendation-development
     January 01, 2014 - The USPSTF recommendation statement on routine use of aspirin or nonsteroidal anti-inflammatory drugs … Routine aspirin or nonsteroidal antiinflammatory drugs for the primary prevention of colorectal cancer

251. Archived: Preeclampsia: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/preeclampsia-screening-1996
     January 01, 1996 - Aspirin prophylaxis for the prevention of preeclampsia and its complications is discussed elsewhere ( … See Chapter 70 for recommendations on the use of aspirin prophylaxis in pregnancy. 

252. Recommendation: Asymptomatic Carotid Artery Stenosis: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/carotid-artery-stenosis-screening
     February 02, 2021 - In adults with cardiovascular risk factors In adults without known cardiovascular risk factors Aspirin … with cardiovascular risk factors 13 In adults without known cardiovascular risk factors 14 Aspirin … Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S.

253. Archived: Coronary Heart Disease: Screening with Electrocardiography | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/coronary-heart-disease-screening-with-electrocardiography-2012
     December 30, 2013 - usually managed with a combination of diet and exercise modifications, lipid-lowering medications, aspirin … The net benefit of the use of aspirin and the intensity of lipid-lowering therapy depends on a person's … Useful Resources The USPSTF has made recommendations on the use of aspirin to prevent CVD, screening

254. Screening for Asymptomatic Carotid Artery Stenosis: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/e6_WqcwDGhgT6bQfmk3Hqj
     February 02, 2021 - In adults with cardiovascular risk factors • In adults without known cardiovascular risk factors • Aspirin … adults with cardiovascular risk factors13 • In adults without known cardiovascular risk factors14 • Aspirin … Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S.

255. Draft Recommendation: Asymptomatic Carotid Artery Stenosis: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/asymptomatic-carotid-artery-stenosis-screening
     August 04, 2020 - adults with cardiovascular risk factors 12 In adults without known cardiovascular risk factors 13 Aspirin … Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S.

256. N3Veybr4Zdhzfqsw3Erlhe (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/N3VeYbr4ZdhZfqsw3ErLHE
     November 01, 2014 - In addition, the USPSTF recommends the use of aspirin for persons at increased risk for cardiovascular … In addition, the USPSTF recommends the use of aspirin for persons at increased risk for cardiovascular … var- ied across trials and was not clearly defined or standardized, although all patients received aspirin … trials include the CASANOVA (Carotid Artery Stenosis with Asymp- tomatic Narrowing: Operation Versus Aspirin

257. Draft Research Plan: Screening for Prediabetes and Type 2 Diabetes Mellitus | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/abnormal-blood-glucose-and-type-2-diabetes-mellitus-screening
     July 05, 2018 - atherosclerotic cardiovascular disease, including more intensive blood pressure control, lipid control, or aspirin

258. Draft Research Plan: Prediabetes and Type 2 Diabetes: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/prediabetes-and-type-2-diabetes-mellitus-screening
     July 05, 2018 - atherosclerotic cardiovascular disease, including more intensive blood pressure control, lipid control, or aspirin

259. Draft Research Plan: Screening for Prediabetes and Type 2 Diabetes | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/prediabetes-and-type-2-diabetes-screening
     July 05, 2018 - atherosclerotic cardiovascular disease, including more intensive blood pressure control, lipid control, or aspirin

260. Final Research Plan: Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan16/screening-for-abnormal-blood-glucose-and-type-2-diabetes
     August 15, 2013 - lifestyle modification KQ 5: Any intervention for more stringent blood pressure or lipid control or aspirin